Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-02-20 @ 12:41 PM
Study NCT ID:
NCT03838367
Status:
TERMINATED
Last Update Posted:
2025-09-09
First Post:
2019-02-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
Sponsor:
CytoDyn, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-16
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-05
First Submit QC Date:
None
Study First Post Date:
2019-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-09
Results First Submit QC Date:
None
Results First Post Date:
2025-09-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-19
Last Update Post Date:
2025-09-09
Last Update Post Date Type:
ESTIMATED